1 Introduction BENIGN PROSTATIC hyperplasia (BPH) is a condition characterised by non-malignant proliferation of tissue within the capsule of the prostate gland, ultimately leading to obstruction of urinary flow through the prostatic urethra. BPH is estimated to effect about 50 per cent of men over the age of 60 years; in men over 80 years of age, 80 per cent are affected (HULBERT, 1989) . The traditional treatment for urinary obstruction due to BPH is the surgical removal of hyperplastic prostatic tissue, usually by endoscopic transurethral reaction of the prostate (TURP). In 1983, approximately 357000 men in the USA underwent prostatic resection, either by transurethral or abdominal approaches (ERCOLE, 1989) . In a multi-centre study, MEBUST et al. (1989) found that, although the surgical mortality due to transurethral resection was low (0-2 per cent), the morbidity of the procedure (failure to void, bleeding requiring transfusions, clot retention, and genito-urinary 
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infections) was 18 per cent. For patients older than 80 years, the morbidity was 22.6 per cent. When the duration of procedure was greater than 90min, intra-operative bleeding requiring a blood transfusion occurred in 7-3 per cent of cases. The cost of TURP for each patient totals about $10000, owing to the need for hospitalisation, surgeon's and anaesthetist's fees and operating room time (CASTANEDA et al., 1987) .
A variety of alternatives to TURP are being investigated. Medical treatment of BPH with endocrine and alpha-adrenergic blocker therapy has been somewhat successful; however, the effects are reported to be temporary (ERCOLE, 1989) . For patients in whom surgery is not indicated, long-term intra-urethral prostheses have been tried to treat urinary flow obstruction (VINCENTE et al., 1989) , but these devices promoted an undesirable incidence of urinary tract infection. Another procedure being investigated is prostatic urethroplasty with a balloon catheter (CASTANEDA et al., 1987) . Reported results from this procedure have been mixed (GoNZALEZ et al., 1989; HERRERA et al., 1989; MACHAN et al., 1989) . Complications include initial haematuria, which usually clears in 24h, severe delayed haemorrhage and acute urinary retention (CASTANEDA, 1989) . Microwave hyperthermia is also under investigation as an alternative to TURP. As with balloon dilatation, the results have been mixed (SAPOZTNK et al., 1990; STROHMAIER et al., 1990 ). Short-term complications of microwave hyperthermia include haematuria, bladder spasm and dysuria. This paper describes theoretical studies of a potential new modality for the minimally invasive treatment of BPH; transurethral thermocoagulation of the prostate. In contrast to hyperthermia therapy at 42-46~ generated by transurethral microwave techniques (SAPOZINK et al., 1990) , thermocoagulation involves the deliberate generation of high temperatures (>60~ for 1 h) sufficient to cause coagulative necrosis of treated periurethral tissue. The goal is to coagulate an annular sleeve of periurethral prostatic tissue, which will subsequently be resorbed with minimal bleeding, followed by regeneration of the urethral epithelium and relief of urinary outflow obstruction.
Technology currently under development for transurethral thermocoagulation includes a 7-10Fr (2.2-3.2mm diameter) catheter containing a wire-wound, electrically heated resistor near the catheter tip (Fig. i) . Catheters may be selected with the heating element ranging from 3 to 4cm in length to match the ultrasonically measured prostatic dimensions in individual patients. A high thermal conductivity elastomer is used to couple the heating element to the polyethylene covering. To monitor and control the temperature of the heating element, a high-precision thermistor is located at the centre of the heating element. In operation, the catheter is placed in the prostatic urethra with the aid of transrectal ultrasonography to verify the catheter position. Direct current is then applied to the catheter and the power is adjusted via computer control such that the internal catheter temperature is held constant. Heat is delivered to the tissue by thermal conduction only, as in other recently developed conductive heating techniques .
Preliminary trials (unpublished study) using this procedure in the canine model have been encouraging. The internal catheter temperatures, ranging from 59 to 87~ were generated for 20-60rain. Histopathologic findings immediately following heat treatment revealed coagulative necrosis extending 1 to 3ram radially from the catheter edge into periurethral stroma and glandular elements. Treated prostate glands studied 2, 4, or 8 weeks after thermocoagulation by retrograde urethrography and light microscopy exhibited a consistent pattern of oedema and non-infective inflammation with minimal luminal narrowing at 2 weeks; followed by resolution of the inflammatory response, re-epithelialisation and widening of the prostatic urethra, and atrophy of the periurethral prostatic glands, with maintenance of the normal architecture of periurethral connective tissue.
To further refine the technique for clinical use, accurate control of catheter placement and heat delivery are necessary, so as to not damage normal tissues, such as the urinary sphincter. This paper describes the use of a computer model to predict temperature distributions created by conductive thermocoagulation of the prostate and to predict the 'kill radius' within which clearly cytotoxic temperatures are achieved. A two-dimensional cylindrical coordinate model, very similar to one previously described , was used, so that temperature gradients could be evaluated in both radial and longitudinal dimensions. Evaluation of the simulated temperature distribution led to the development of a rapidly computable predictor of periprostatic temperature distributions.
Computational methods

Theory
The computational formulae used in this study were based on the bioheat transfer equation first described by PENNES (1948) for a small control volume of tissue:
where qmet is the specific rate of metabolic heat production, P is the power density delivered to tissue, K is the tissue thermal conductivity, T is the temperature of tissue, c b is the specific heat of blood, w b is the specific flow rate of blood in capillaries, T b is the temperature of blood, p is the mass density of tissue, e is the specific heat of tissue and t is time. The control volume is small enough that all thermal properties within it are uniform. For an interstitial, conductive heating modality at steady state, metabolic heat production is small compared with other terms (DEFORD, 1989), power is not directly delivered to the tissue, and OT/Ot -~ O. Thus, eqn. 1 simplifies to 
Modelled volume
The prostate and surrounding tissue were modelled in a cylindrical space, assuming radial symmetry. Fig. 2 shows a sketch of the model space in cross-section. The urethra was modelled as a potential space occupied by the heatemitting catheter along the central axis. The prostate region was modelled as the middle elliptical portion of the cylinder. The bladder was modelled as the top of the cylinder containing fluid at 37~ This section tapered down to the urethra. Just below the prostate, the external, voluntary sphincter was modelled as ring of tissue 1 cm thick with a radius of 2 cm. The remaining volume of the cylinder was modelled as surrounding connective tissue. The outer edge of the cylinder, x = 3cm, was clamped to arterial blood temperature, 37~ The bottom of the cylin-der was also clamped to arterial blood temperature.
The control volumes in this model were similar to the control volumes described by PATEL et al. (1991) for computer simulation of hyperthermia therapy in brain tumours. Except for the central axis, each control volume was a ring of tissue. Heat conduction occurred radially between control volumes of the same height and longitudinally between control volumes of the same radius. In this study, each ring had a height dz of 0.04 cm and a width dr of 0-01 cm. Thus, the entire model space contained 60000 control volumes. Even though this was a two-dimensional model, incorporating radial symmetry for simplicity, the large number and small sizes of the control volumes were necessary to obtain valid numerical results in the presence of the steep thermal gradients dT/dr associated with conductive heating.
Computational formulae and simulations
The computational formulae and the methods were identical to those previously derived . The following shows the computational formula used to obtain an iterative solution to the steady-state bioheat transfer equation for the temperature rise above arterial blood temperature (Oc) for the centre control volume shown in Fig. 3 , which represents a typical ring of tissue:
0 x is the temperature rise above arterial blood temperature for control volume x, Kxy is the interface thermal conductivity between control volumes x and y (DeFoRD et al., 1990) , r is radial distance to the centre control volume, Cb is the specific heat of blood and Wb is the blood perfusion in the tissue control volume. The subscripts C, I, O, U and L are as defined in Fig. 3 . For control volumes containing the heating element, a power deposition term was added to the numerator, and the perfusion term c b w b in the denominator was zero. For other areas of the model space, in which there would be no blood flow (i.e. the catheter components, bladder fluid), the perfusion term was also zero.
Values for the specific heat of blood (3642.6 J kg-1 ~ 1) and for tissue thermal conductivity (0.564Wm-1~ -1) were taken from the literature (ALBRITTON, 1952; COOPER and TREZEK, 1971) . The thermal conductivities of the catheter components were obtained from the literature (INCROPERA and DEWITT, 1981) , or measured experimentally, as described previously .
A modified Gauss-Seidel method was used to solve the derived bioheat transfer equations for each control volume iteratively, beginning with an initial condition of 0 = 0 everywhere. The simulations were run on the Ardent Titan-P3 computer (Ardent Computer Corp.) which was running at 60MIPS. Each simulation required approximately 1-3 h to complete.
The output from a simulation was a file containing the steady-state temperature rise for each control volume for given conditions of catheter power and tissue perfusion. Contour plots were generated from these data and the thermal profiles were evaluated. Temperature profiles from a total of 40 simulations were analysed. Catheter power 
Diagram showing heat conduction between interior control volumes centre(C), inner (I), outer (0), upper (U), and lower (L). Heat conduction occurs radially between control volumes, I, C and O, and occurs longitudinally between control volumes U, C, and L. Each control volume has width dr and height dz
fusion was 0.1 ml min-tg 1. Thus, a large family of simulations was performed, the analysis of which revealed helpful regularities in the thermal responses to this geometrically simple heat treatment modality. In turn, it was possible to derive a much simpler predictor of tissue temperature for use in clinical work than the complete bioheat equation. 10 nal temperature gradients developed only at the ends of the heating element. Fig. 5 shows a plot of radial temperature profiles in a plane containing the midpoint of the heating element (z = 2.5 cm in Fig. 4 ) from five simulations of different catheter power (0.5-1.0Wcm -1) and a constant blood perfusion of 0.2mlmin-lg 1. The radial distance x in this plot is zero at the centre of the catheter. The temperature profiles obtained were dependent on catheter power. To normalise the results, the ratio of temperature rise above arterial blood temperature to catheter power in W cm ~ was plotted against radial distance (Fig.  6a) , and the curves collapsed to a single curve. Fig. 6b shows this normalisation for all perfusion levels simulated. Each curve in Fig. 6b represents five different power levels and one perfusion level. The relationship shown in Fig. 6b was then used to develop a predictor of radial tissue temperature that would require far less computation time than the solution of the entire bioheat equation for 60000 control volumes.
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Predictor development
The curves shown in Fig. 6b were offset from each other due to different levels of perfusion. Thus, an equation governing the behaviour of the curves would have the following form:
T-T.
---f(co, r) (4) Pc
Pc is catheter power in Wcm-1 T -T~ is the tissue temperature rise above arterial blood temperature in ~ r is the distance away from the catheter edge (x-re) in cm, 09 is the prostate blood perfusion in ml min-1 g -t andf(~o, r) is a function dependent on perfusion and distance in ~ W 1 cm-1. As the curves in Fig. 6b were quasi exponentia/in nature, f(cg, r) was assumed to be an exponential function. Thus f(co, r) = e at~ n or (5)
Therefore, to find 0(o), r), In (T-T,/Pc) was plotted against distance r for all simulated perfusion levels (Fig. 7) . For r > 0.5cm, a nearly linear family of curves was obtained and for r ~< 0.5cm, the curves appeared to be second-order. Thus, to approximate 9(03, r), the radial dimension was divided into two regions; near field (r ~< 0-5cm) and far field (r > 0.5cm). For the near field, 9(03, r) was of the form ar 2 + br + C, where the coefficients a, b and c were dependent on perfusion. Using secondorder regression analysis, the coefficients a, b, and c were found for each perfusion level that was simulated. Table 1  summarises 0.05 1.59 -2.98 4.12 1.00 -1.54 3"77 1.00 0"1 1.67 --3.27 4-05 1"00 -1.72 3.64 1-00 0.2 1.77 --3.71 3-94 1-00 -2-05 3"50 1-00 0"3 1.84 -4.07 3-86 1"00 -2.34 3.40 1"00 0.4 1"89 -4.37 3-80 1.00 -2-62 3"34 1-00 0'5 1-94 -4.64 3-74 1.00 -2"83 3"25 1"00 0.6 1-97 -4.88 3-70 1-00 -3.03 3.21 1"00 0"7 2-00 -5.10 3"66 1"00 -3"23 3.16 1.00 (Table 1) . Then the coefficients m and b were plotted against perfusion and an additional regression analysis was performed to obtain quadratic equations to describe the far-field coefficient values in terms of perfusion. Table 2 summarises the second-order fits for the coefficient values in terms of perfusion. Substituting the functions f(03, r) and 9(03, r) in eqn. 5 for the near field and far field, respectively, the estimators of eqns. 7 and 8 were obtained: 
T -T, = Pc exp (1.5203 2 --3.7103 -1.36)r + (1.1203 2 --1.7103 + 3.82)
Eqn. 7 is a near-field estimator and eqn. 8 is the far-field estimator. These estimators could be used to find tissue temperature rise at any distance in the radial direction from the catheter edge within the heating space.
It is important to note that these estimators do not give valid answers for perfusion levels greater than 1-0ml min 1 g 1. If perfusions are greater than 1.0mlmin-1 g 1, predicted temperatures are overestimated. For prostatic blood perfusion levels modelled within the physiological range, 0.15 0.79mlmin-lg 1 (ANDERSON et al., 1967; HAEENER and LIAVAG, 1969) , temperature estimates are accurate. Figs. 8a and 8b present three-dimensional plots showing the behaviour of the near-and far-field estimators as a function of prostatic blood perfusions less than 1.0mlmin i g 1 and of radial distances less than 2"5cm.
The temperature estimators of eqns. 7 and 8 are not clinically useful unless perfusion can also be estimated. DEFORD et al. (1992) showed that, in conductive heating, tissue perfusion could be estimated if catheter power and catheter temperature rise were known. Fig. 9 shows a plot of perfusion against the ratio of catheter power to catheter temperature rise above arterial blood temperature (defined as a : Pc/T~-To) obtained from the simulations run in this study. Each triangle represents five overlapping data points at different power levels. Second-order regression analysis yielded the following equation that predicts perfusion in terms of o: 03 = 12665.1a 2 -292-5cr + 1'7
Positive values for co are obtained only when a is greater than 0-0115Wcm-l~ -1. In unpublished experimental studies, a has been well above this value. Thus, by calculating perfusion with eqn. 9 in terms of clinical variables that can be readily measured on-line (catheter power and catheter temperature), eqns. 7 and 8 can then be used to predict prostatic tissue temperature at any distance radially away from the catheter edge.
Conversely, it is possible to predict the radial distance from the catheter within which thermocoagulation is expected to occur. From the work of JAIN and DUDAR (1983) , we can expect coagulation necrosis to occur in tissue raised to 47~ or more for a minimum of 50min. In unpublished animal studies, the 47~ contour appears to circumscribe the zone of grossly and histologically observable necrosis of prostatic tissue after transurethral thermocoagulation in the dog model. Solving eqn. 8 for r at 47~ we obtain In (47 -37) -In (Pc) -1"12032 + 1.7103 -3.82 ~'47 :
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1"5203 2 -3'7103 -1"36 (lO) for r47 in the far field. Similar analysis can be performed to obtain r47 for the near field. If the calculated value for r47 is less than 0.5cm, r~ should be recalculated using the near-field estimator equation. Thus, the extent of thermocoagulation can be predicted by on-line measurements of catheter power and temperature, based on the prior computer solutions of the bioheat transfer equation presented here. If the predicted kill radius is insufficient, then the power can be increased during therapy to achieve a target therapeutic coagulation radius. Conversely, if the computed kill radius is too large, the power can be decreased.
Predictor verification
To validate the accuracy of the predictor, tissue temperatures calculated by the predictor were compared with those obtained from computer simulations. This comparison was performed for two cases: the first, in which catheter power was high and perfusion was low; and the second, in which catheter power was low and perfusion was high. In the first case the computer simulation produced a large thermal gradient, and in the second case the computer simulation produced a small thermal gradient. Fig. 10 shows plots of radial thermal profiles produced from computer simulations (solid lines) and the radial thermal pro- Fig. 8 files calculated using the tissue temperature estimators from eqns. 7-9 (broken lines). The upper curves represent profiles using a catheter power of 1-0 W cm-~ and a tissue perfusion of 0.05 mlmin i g-1, and the lower curves represent profiles using a catheter power of 0.5 W cm-~ and a tissue perfusion of 0.7mlmin ~g-a. In the first case the r47 was 1.02 cm simulated against 1.01 cm predicted; in the second case the r47 was 0.24cm simulated against 0.24 cm predicted. 
D i s c u s s i o n
This paper presents the development of a rapidly computable, on-line tissue estimator for prostatic tissue during transurethral prostatic thermocoagulation. The model used to develop the predictor assumed that the geometry of the prostate was symmetrical around the urethra, the thermal properties were uniform, and tissue perfusion was homogeneous within the prostate. Provided that the thermal conductivities of the prostate and surrounding tissue are of the same order of magnitude, the assumption of a cylindrical prostate as opposed to a lobular prostate should have no effect on predictor accuracy. The accuracy of prediction is also dependent on the accuracy of the perfusion estimate. Sensitivity analysis showed that, if per- fusion is estimated to within 25 per cent of the actual value, r47 is within 0.7 m m of the actual value as calculated by eqn. 10. DEFORD et al. (1992) showed that perfusion inhomogeneities should not be a factor in temperature predictor accuracy as long as variations are less than 25 per cent. Finally, this model also assumes that the catheter is placed completely within the prostatic urethra. If the catheter was misplaced within the bladder and the bladder contained urine, the power required to heat the catheter would increase due to convective heat losses in the bladder. Such a situation would cause the predicted temperatures to be underestimated. Thus, accurate placement of the catheter is necessary for the predicter to estimate temperatures properly. This predictor has the ability to estimate mid-plane tissue temperature at any radial distance from the catheter. If desired, a similar technique to that used in this study could be supplied to develop a predictor for temperatures in the longitudinal direction. Tissue temperatures could be predicted on-line in major regions of the prostate and important peri-prostatic tissues. Knowledge of the expected thermal profiles could then be used to adjust catheter power so as to achieve a desired therapeutic effect. Thus, conductive heat could be applied effectively to the prostate to create a desired radius of thermocoagulation (r47) sufficient to relieve obstructive symptoms, after resorption of the coagulated tissues. The most suitable r47 value could be readily learned from clinical experience. Then subsequent patients could be treated with sufficient power, adjusted moment by moment during treatment, to produce the prescribed r47. In this way, formulae derived would allow physicians to write in advance a geometric prescription for thermocoagulation of the prostate.
